Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Headlines

Follow companies to personalize your feed

Today
Advanced Medical Solutions Group PlcBusiness
Form 8.3 - Advanced Medical Solutions Group plc - Octopus Investments
16 minutes ago
Animalcare Group PlcBusiness
Form 8.3 - Animalcare Group plc - Octopus Investments
17 minutes ago
American Water WorksU.S.
American Water Participates in U.S. Conference of Mayors Spring 2026 Water Council Meeting
29 minutes ago
Cineverse Corp.Business
Cineverse Announces Matchpoint Hex™ - the Entertainment Industry's First System to Classify the Human Experience Power Next-Generation Search & Discovery, Content Programming and Contextual Advertising
29 minutes ago
Fast Finance Pay Corp.Business
Fast Finance Pay Corp. Launches OK.pay, Advancing OK.secure Into Scalable Payments Ecosystem
29 minutes ago
Choice Hotels International IncBusiness
Choice Hotels International Leverages AI Across Its Enterprise with Amazon Web Services, Setting a New Standard for Hospitality Innovation
30 minutes ago
Pultegroup IncBusiness
PHM Announces 2026 PHM HealthFront Talent & Programming
30 minutes ago
Hesai GroupTechnology
Hesai Unveils Picasso 6D Full-Color SPAD-SoC, Next-Gen ETX, and Innovations in Spatial Intelligence and Physical AI
30 minutes ago
Compass Minerals International IncBusiness
ALL INDIVIDUALS WHO PURCHASED COMPASS MINERALS INTERNATIONAL, INC., COMMON STOCK BETWEEN MARCH 2, 2017, AND OCTOBER 23, 2018
43 minutes ago
La-z-boy IncorporatedBusiness
La-Z-Boy Incorporated Introduces AudioLuxe, a New Premium Audio Furniture Line with Sound by Klipsch
44 minutes ago
Terreno Realty CorporationBusiness
Terreno Realty Corporation Announces Lease in Hayward, CA
44 minutes ago
Datasea IncBusiness
Datasea Intelligent Technology Ltd. Completes Delivery of Three AI Multimodal Solution Projects with Aggregate Contract Value of Approximately USD 1.01 Million
44 minutes ago
Intelligent Bio Solutions Inc.Business
Intelligent Bio Solutions Initiates Validation Study for Rapid Drug Screening Cartridge Targeting 70% Faster Results
44 minutes ago
Stardust Power Inc.Business
Stardust Power Secures Institutional Investment Framework Supporting Up to $150 Million Investment
44 minutes ago
Anaptysbio IncBusiness
Anaptys Completes Separation of First Tracks Biotherapeutics and Now Exclusively Manages GSK and Vanda Financial Collaborations
44 minutes ago
Oracle CorporationBusiness
Oracle Health Demonstrates Interoperability Leadership, Achieves CMS Aligned Network Status
44 minutes ago
Gbank Financial Holdings Inc.Business
GBank Financial Holdings Inc. Announces First Quarter 2026 Quarterly Earnings Call Scheduled for Wednesday, April 29th, at 2:00 P.M., Pacific Time
an hour ago
Lumen Technologies IncBusiness
Lumen Technologies, Inc. and Qwest Corporation Announce Commencement of Exchange Offers and Consent Solicitations and Intention to Delist Notes
an hour ago
Community Health Systems IncBusiness
Community Health Systems Invests for Strategic Growth in Ambulatory Surgery Centers
an hour ago
Super League Enterprise Inc.Business
Super League Issues Letter Encouraging Shareholders to Vote in Support of the Misfits Ads Division Acquisition
an hour ago
Business
16m ago
3 min read

Form 8.3 - Advanced Medical Solutions Group plc - Octopus Investments

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

OCTOPUS INVESTMENTS LTD

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):
The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:
Use a separate form for each offeror/offeree

Advanced Medical Solutions Group plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:
For an opening position disclosure, state the latest practicable date prior to the disclosure

17/04/2026

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
If it is a cash offer or possible cash offer, state “N/A”

No

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

Ordinary 5p (GB0004536594)

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:





20,971,015





9.55

(2) Cash-settled derivatives:

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:



TOTAL:

20,971,015

9.55

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

Number of securities

Price per unit

Ordinary 5p

Sale

7,060

2.225

(b) Cash-settled derivative transactions

Class of relevant security

Product description
e.g. CFD

Nature of dealing
e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type
e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(ii) Exercise

Class of relevant security

Product description
e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing
e.g. subscription, conversion

Details

Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”



None



(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state “none”



None



(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO


Date of disclosure:

20/04/2026

Contact name:

Andrea Penton

Telephone number/email:

[email protected]

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.


DISCLAIMER OF LIABILITY

6ix Inc. ("6ix") licenses software to publicly traded issuers of securities ("Issuers" and each an "Issuer") which can be used by Issuers to communicate with current and prospective investors ("Investors" and each an "Investor") on the online platform maintained by 6ix Inc. at www.6ix.com (the "Platform"). Each Issuer is solely responsible for all content relating to the Issuer on the 6ix Platform, including without limitation all investor summits presented by the Issuer and all summary information about the Issuer on the 6ix Platform.

All content provided on the 6ix Platform is for informational and educational purposes only and should not be construed as investment advice or an offer or solicitation in respect to any products or services. The content presented on the 6ix Platform should not be used as the basis for any investment decision, and does not purport to provide any legal, tax or accounting advice. There are inherent risks involved with investing in Issuers, as set out in the public disclosure record of each Issuer. Issuers are not responsible for revising or updating any information that they present on the 6ix Platform.

Investors should refer to the continuous disclosure documents filed by each Issuer under applicable securities laws, including risk factors and warnings regarding "forward looking information". Issuers are solely responsible for compliance with applicable securities laws, and 6ix makes no representations and provides no assurances to Investors regarding the accuracy or truthfulness of information presented by Issuers on the 6ix Platform or in their public disclosure records.

6ix is not licensed to trade, deal or advise in securities in any jurisdiction. 6ix does not recommend or endorse any Issuer on the 6ix Platform, nor does 6ix verify the accuracy of any information presented by Issuers to Investors on the 6ix Platform or in their public disclosure records. 6ix's sole responsibility as the operator of the 6ix Platform is to provide software to Issuers and Investors through which Issuers and Investors communicate directly with each other without any intermediation or intervention by 6ix other than in respect of technical, logistical or advertising and marketing support. Issuers pay 6ix a licensing fee for use of the 6ix Platform, and 6ix may also receive payment from Issuers to pay for advertising on third-party websites. 6ix and its principals may make and hold investments in securities of Issuers on the 6ix Platform and 6ix may offer reduced rates for its software services to Issuers in which 6ix and/or its principals are invested.

ALL CONTENT ON THE PLATFORM IS PROVIDED BY THE ISSUERS "AS IS" AND "AS AVAILABLE". 6IX DOES NOT GUARANTEE THE ACCURACY OF ITS CONTENT. BY USING THE PLATFORM, EACH INVESTOR AGREES TO ACCEPT ANY RISKS ASSOCIATED WITH THE USE OF THE PLATFORM AND ACKNOWLEDGES THAT 6IX IS NOT RESPONSIBLE FOR ANY CONTENT PRESENTED BY OR RELATING TO ISSUERS ON THE PLATFORM.

6IX DOES NOT WARRANT THAT THE PROVISION OF INFORMATION BY ISSUERS ON THE PLATFORM WILL BE ERROR-FREE, TIMELY, COMPLETE OR ACCURATE. USE OF THE PLATFORM AND RELIANCE THEREON IS AT INVESTOR'S SOLE RISK. 6IX WILL NOT BE IN ANY WAY BE LIABLE TO ANY INVESTOR OR ISSUER OR ANY OTHER ENTITY OR PERSON FOR ANY INACCURACIES, ERRORS, OMISSIONS, DELAYS, DAMAGES, CLAIMS, LIABILITIES OR LOSSES, REGARDLESS OF CAUSE, IN OR ARISING FROM THE USE OF THE PLATFORM.

IN NO EVENT WILL 6IX BE LIABLE FOR ANY DAMAGES, INCLUDING WITHOUT LIMITATION DIRECT OR INDIRECT, SPECIAL, INCIDENTAL, OR CONSEQUENTIAL DAMAGES, LOSSES OR EXPENSES ARISING IN CONNECTION WITH THE USE OF THE PLATFORM BY INVESTORS AND/OR ISSUERS EVEN IF 6IX IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES, LOSSES OR EXPENSES. FURTHER, 6IX SHALL NOT BE LIABLE IN ANY MANNER FOR THE PRODUCT OR SERVICES OF ANYONE WHO REDISTRIBUTES THE INFORMATION PROVIDED ON THE PLATFORM, AND SUCH REDISTRIBUTION IS EXPRESSLY PROHIBITED.